NCT00491777|CompletedPhase 1DMC
Correlation Research Study: IQ2, NcIQ and IQ101
NMT-CT
Correlation Study of NMT's IQ2, NcIQ and Its' Predicate Technology, IQ101.
Loading search results
Sponsor study identifier
interventional
25
0 countries
N/A
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
June 2007
Actual (reported)The new NcIQ thoracic impedance monitor is based on the predicate device, the IQ101. The new model uses the same 3-dimensional signal averaging as the original device, but also include second radio frequency signal to permit the device to work "wirelessly", i.e., without electrode lead attachments to the patient. This study seeks to 1) validate the use of the new device and confirm the correlation of the IQ101 and NcIQ. 2) Evaluate the ease of the new device. The new IQ2 thoracic impedance monitor is based on the predicate device, the IQ101. The new model uses the same 3-dimensional signal averaging as the original device, but with smaller housing and updated operating software. This study seeks to 1) Validate the use of the new device and confirm the correlation of the IQ101 and IQ2. 2) Compare the ease of the devices.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2007
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
June 2007
Actual (reported)June 22, 2007
Actual (reported)June 26, 2007
Actual (reported)A direct correlation between output parameters of IQ2/NcIQ to IQ101
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Kevin Ferguson, MD
Shand's Hospital
Joseph A Tyndall, MD
Shand's Hospital
David Seaberg, MD
Shand's Hospital
25 participants (actual enrollment reported by the registry).
First Submitted
June 22, 2007
First Posted
June 26, 2007
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions
Contact the study team to confirm eligibility.
Study Completion
June 2007
Actual (reported)Last Updated
June 26, 2007
Record last verified: 2007-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: